Purine metabolism

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Many organisms have metabolic pathways to synthesize and break down purines.

Contents

[edit] Synthesis

Purines are biologically synthesized as nucleotides (bases attached to ribose 5-phosphate). The committed step is amidophosphoribosyltransferase.

Both adenine and guanine are derived from the nucleotide inosine monophosphate (IMP), which is synthesised on a pre-existing ribose-phosphate through a complex pathway using atoms from the amino acids glycine, glutamine, and aspartic acid, as well as formate ions transferred from the coenzyme tetrahydrofolate.

[edit] GMP

[edit] AMP

[edit] Degradation

Purines are metabolised by several enzymes:

[edit] Guanine

[edit] Adenine

[edit] Salvage

Purines from turnover of nucleic acids (or from food) can also be salvaged and reused in new nucleotides.

[edit] Disorders

When a defective gene causes gaps to appear in the metabolic recycling process for purines and pyrimidines, these chemicals are not metabolised properly, and adults or children can suffer from any one of twenty-eight hereditary disorders, possibly some more as yet unknown. Symptoms can include gout, anaemia, autism, epilepsy, delayed development, deafness, compulsive self-biting, kidney failure or stones, or loss of immunity.

[edit] Pharmacotherapy

Modulation of purine metabolism has pharmacotherapeutic value.

Purine synthesis inhibitors inhibit the proliferation of cells, especially leukocytes. These inhibitors include azathioprine, an immunosuppressant used in organ transplantation, autoimmune disease such as rheumatoid arthritis or inflammatory bowel disease such as Crohn's disease and ulcerative colitis.

Allopurinol is a drug which inhibits the enzyme xanthine oxidoreductase and thus lowers the level of uric acid in the body. This may be useful in the treatment of gout, which is a disease caused by excess uric acid forming crystals in joints.

[edit] External links

Languages